Vascular Diseases

The Vascular Diseases Learning Pathway at ACC.26 will deliver practice-changing updates and highly interactive sessions spanning the full spectrum of vascular medicine. Designed for the entire cardiovascular team, this year's program features lively debates, case-based journeys and innovative formats that translate new science into everyday care.

Building on prior years, the pathway broadens its focus on high-stakes decision-making and cross-disciplinary collaboration. Sessions will highlight key developments in chronic limb-threatening ischemia, pulmonary embolism, peripheral arterial disease and renal denervation. Attendees will explore landmark trial data, new interventional and medical therapies, and discussions on carotid revascularization, hypertension device therapy, and vascular complications arising from oncology and reproductive health treatments.

The program will also tackle major controversies shaping the field, from who benefits most from revascularization in CLTI and carotid disease to whether renal denervation is ready for prime-time implementation. Through expert dialogue and active audience participation, each session is designed to challenge assumptions and strengthen clinical confidence across the continuum of vascular care.

Sessions You Don't Want to Miss:

• Beyond the Numbers: Intimate Insights into Optimizing CLTI Outcomes (Session 328)
• Who Wants to Beat the Clot? Learning the 2026 PE Guidelines (Session 292)
• Pulmonary Embolism in 2026: A Case-Based Journey From Diagnosis to Recovery (Session 263)
• Renal Denervation Decoded: Your Questions, The Experts' Answers (Session 209)
• Debates and Dilemmas in Carotid Artery Disease (Session 338)

Join us for forward-thinking sessions, expert perspectives and practical takeaways that will leave you inspired and ready to advance care for patients with vascular disease.